Last reviewed · How we verify

NCT03832894

Oestradiol Supplementation in Luteal Long Agonist Fresh In Vitro Fertilization/Intra Cytoplasmic Sperm Injection ( IVF/ICSI) Cycle .

Status unknown Phase 3 Last updated 7 February 2019
What this trial tests

Phase 3 trial testing Estradiol Valerate in Infertility in 2 participants. Status unknown.

Timeline
1 December 2018
Primary endpoint
1 December 2019
1 January 2020

Quick facts

Lead sponsorCairo University
PhasePhase 3
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingdouble
Primary purposeother
Enrollment2
Start date1 December 2018
Primary completion1 December 2019
Estimated completion1 January 2020
Sites1 location across Egypt

Drugs / interventions tested

Conditions studied

Sponsor

Cairo University

Who can join

Adults 20 to 38, female only, with Infertility. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Whether oestradiol administration affects the pregnancy rate in long agonist fresh IVF/ICSI cycles. Oestradiol level will be measured the day of HCG trigger to assess whether oestradiol level affects cycle outcome results.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Estradiol Valerate

Trials testing the same drug.

Other recruiting trials for Infertility

Currently open trials in the same condition.

Other Cairo University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03832894.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing